These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22312307)

  • 1. The effect of temozolomide/poly(lactide-co-glycolide) (PLGA)/nano-hydroxyapatite microspheres on glioma U87 cells behavior.
    Zhang D; Tian A; Xue X; Wang M; Qiu B; Wu A
    Int J Mol Sci; 2012; 13(1):1109-1125. PubMed ID: 22312307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats.
    Zhang YH; Zhang H; Liu JM; Yue ZJ
    Med Oncol; 2011 Sep; 28(3):901-6. PubMed ID: 20396980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
    Ling Y; Wei K; Zou F; Zhong S
    Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCNU-loaded poly(D, L-lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro.
    Seong H; An TK; Khang G; Choi SU; Lee CO; Lee HB
    Int J Pharm; 2003 Jan; 251(1-2):1-12. PubMed ID: 12527170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged release from PLGA/HAp scaffolds containing drug-loaded PLGA/gelatin composite microspheres.
    Tang G; Zhang H; Zhao Y; Li X; Yuan X; Wang M
    J Mater Sci Mater Med; 2012 Feb; 23(2):419-29. PubMed ID: 22095448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro.
    Zhang H; Gao S
    Int J Pharm; 2007 Feb; 329(1-2):122-8. PubMed ID: 17000068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
    Mao J; Meng X; Zhao C; Yang Y; Liu G
    Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin-/TMZ-coloaded microspheres exert synergistic antiglioma efficacy via inhibition of β-catenin transactivation.
    Shi ZD; Qian XM; Liu CY; Han L; Zhang KL; Chen LY; Zhang JX; Pu PY; Yuan XB; Kang CS;
    CNS Neurosci Ther; 2013 Feb; 19(2):98-108. PubMed ID: 23230963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives.
    Chung TW; Tsai YL; Hsieh JH; Tsai WJ
    J Microencapsul; 2006 Feb; 23(1):15-27. PubMed ID: 16830974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications.
    Shi X; Wang Y; Ren L; Gong Y; Wang DA
    Pharm Res; 2009 Feb; 26(2):422-30. PubMed ID: 18979188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM-PLGA microspheres for bone cancer treatment.
    Rong ZJ; Yang LJ; Cai BT; Zhu LX; Cao YL; Wu GF; Zhang ZJ
    J Mater Sci Mater Med; 2016 May; 27(5):89. PubMed ID: 26975746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different sintering methods on bioactivity and release of proteins from PLGA microspheres.
    Dormer NH; Gupta V; Scurto AM; Berkland CJ; Detamore MS
    Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):4343-51. PubMed ID: 23910352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(lactide-co-glycolide)/hydroxyapatite nanofibrous scaffolds fabricated by electrospinning for bone tissue engineering.
    Lao L; Wang Y; Zhu Y; Zhang Y; Gao C
    J Mater Sci Mater Med; 2011 Aug; 22(8):1873-84. PubMed ID: 21681656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
    Ghassemi AH; van Steenbergen MJ; Barendregt A; Talsma H; Kok RJ; van Nostrum CF; Crommelin DJ; Hennink WE
    Pharm Res; 2012 Jan; 29(1):110-20. PubMed ID: 21744173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis.
    Cevher E; Orhan Z; Sensoy D; Ahiskali R; Kan PL; Sağirli O; Mülazimoğlu L
    J Microencapsul; 2007 Sep; 24(6):577-95. PubMed ID: 17654177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.
    Lin Y; Li Y; Ooi CP
    J Mater Sci Mater Med; 2012 Oct; 23(10):2453-60. PubMed ID: 22843166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells.
    Kim TH; Jeong YI; Jin SG; Pei J; Jung TY; Moon KS; Kim IY; Kang SS; Jung S
    Int J Nanomedicine; 2011; 6():2621-31. PubMed ID: 22114493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Nano-hydroxyapatite/Poly(DL-lactic-co-glycolic acid) Microsphere-Based Composite Scaffolds on Repair of Bone Defects: Evaluating the Role of Nano-hydroxyapatite Content.
    He S; Lin KF; Sun Z; Song Y; Zhao YN; Wang Z; Bi L; Liu J
    Artif Organs; 2016 Jul; 40(7):E128-35. PubMed ID: 27378617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of ciclosporin A loaded poly (D,L lactide-co-glycolide) microspheres using modulated temperature differential scanning calorimetry.
    Passerini N; Craig DQ
    J Pharm Pharmacol; 2002 Jul; 54(7):913-9. PubMed ID: 12162709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
    J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.